South Africa National Viral Hepatitis Technical Working Group (National program)

South Africa National Viral Hepatitis Technical Working Group (National program)

Virus targets
Hepatitis B
Hepatitis C
Type
Testing and treatment implementation
Setting
National
Other targets
HIV
Tuberculosis
Phase
Active
Health outcomes
Incidence
Mortality
Prevalence
WHO region
African Region
Country
South Africa
Key interventions
Blood safety
Community mobilization
Hepatitis B Vaccination
Injection safety and infection control
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
Strategic data analysis
Screening and diagnosis
Treatment
Target population
Adults (> 19 years of age)
Blood transfusion recipients
Household contact(s)
Infants (less than one year of age)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Pregnant women
Sexual contact(s)
Performance target
Blood safety
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
Harm reduction (access to safe injection equipment for persons who inject drugs)
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Performance target additional info

90% reduction in incidence by 2030
Reduce hepatitis B infection rates in children to less than 2% by 2030
65% reduction in hepatitis B and C mortality by 2030

 

Summary and objectives

The National Viral Hepatitis Management Guidelines have been adopted and an action plan has been costed. A Technical working group has been constituted comprising 3 subcommittees to implement the guidelines:

1. HBV Birth Dose Sub-committee:
• Updating the EPI schedule, the National Indicator Data Sets, registers and data collection tools
• Developing field guide for training
• Training of Master Trainers (9 provinces)
• Conducting the cold chain audit
• Engaging external stakeholders
• Developing, printing and distributing IEC materials
• Distribute Vaccines & consumables at facilities
• Monitoring and supervision
• Introduce HBsAg screening into current antenatal program

2. Healthcare Worker Screening, Vaccination and Training program
• Raise awareness among health care workers of viral hepatitis burden and risk, and SA's new national guidelines for prevention, diagnosis, and treatment
• Conduct national representative sero-surveys (institution, regional, provincial data) to establish reliable epidemiology data
• National Train-the-Trainer program in all 9 provinces - capacity building workshops included in training on dolutegravir
• Develop medical educational tools for health care workers and the public
• Develop and distribute easy-to-follow treatment algorithms
• Develop a national network of viral hepatitis treatment centers

3. Key Population program
• Establish screening and linkage to care programs to ensure all HCV and HBV positive individuals are linked to care – preferably at community based centres
• HBV vaccination as standard of care
• Establish DAA therapy as a form of prevention
• Motivate for the registration of DDA therapy
• Motivate for state-funded harm reduction services

 

Last updated